Variant report
Variant | nsv581338 |
---|---|
Chromosome Location | chr2:34267179-34290968 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:25)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:25 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:34282589-34282874 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr2:34282612-34282876 | A549 | lung: | n/a | n/a |
3 | CTCF | chr2:34277080-34277230 | RPTEC | kidney: | n/a | n/a |
4 | E2F4 | chr2:34289805-34290093 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | EP300 | chr2:34267505-34267860 | T-47D | breast: | n/a | n/a |
6 | ESR1 | chr2:34267539-34267867 | T-47D | breast: | n/a | n/a |
7 | FOXA1 | chr2:34267493-34267675 | T-47D | breast: | n/a | n/a |
8 | GATA3 | chr2:34267452-34267789 | T-47D | breast: | n/a | n/a |
9 | JUN | chr2:34282669-34282870 | HepG2 | liver: | n/a | chr2:34282729-34282742 |
10 | JUN | chr2:34267121-34267321 | K562 | blood: | n/a | n/a |
11 | MAFF | chr2:34284189-34284438 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr2:34284166-34284362 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr2:34283943-34284451 | HepG2 | liver: | n/a | chr2:34283969-34283980 chr2:34283970-34283981 chr2:34283968-34283982 chr2:34283969-34283980 |
14 | MAFK | chr2:34284151-34284332 | IMR90 | lung: | n/a | n/a |
15 | POLR2A | chr2:34282808-34282908 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr2:34289929-34289994 | A549 | lung: | n/a | n/a |
17 | POLR2A | chr2:34268782-34268982 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr2:34270924-34270967 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr2:34275659-34275692 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr2:34286602-34286721 | ProgFib | skin: | n/a | n/a |
21 | RAD21 | chr2:34281581-34281875 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | RAD21 | chr2:34281688-34281905 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | RAD21 | chr2:34281579-34281951 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | USF2 | chr2:34281589-34281595 | HepG2 | liver: | n/a | n/a |
25 | ZNF143 | chr2:34290294-34290318 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RASGRP3-1 | chr2:34286086-34286114 | ENSG00000203386 |
2 | lnc-RASGRP3-2 | chr2:34288818-34293939 | NONHSAT070031 |
3 | lnc-RASGRP3-1 | chr2:34285817-34285994 | ENSG00000203386 |
4 | lnc-RASGRP3-2 | chr2:34284362-34284586 | NONHSAT070031 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237790 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530148863 | chr2:34270404-34270405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149550005 | chr2:34270416-34270417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555909755 | chr2:34270420-34270421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77884641 | chr2:34270435-34270436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74435571 | chr2:34270449-34270450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552868652 | chr2:34270463-34270464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566646204 | chr2:34270472-34270473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544661391 | chr2:34270474-34270475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566297212 | chr2:34270490-34270491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79421865 | chr2:34270498-34270499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370528539 | chr2:34270576-34270577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546781421 | chr2:34270594-34270595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191169519 | chr2:34275008-34275009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138979338 | chr2:34275052-34275053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543769923 | chr2:34275067-34275068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13402466 | chr2:34275103-34275104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572368190 | chr2:34275127-34275128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183962152 | chr2:34275145-34275146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552782759 | chr2:34275147-34275148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559523997 | chr2:34275166-34275167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78017324 | chr2:34275184-34275185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553496785 | chr2:34275186-34275187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188659894 | chr2:34275193-34275194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192736467 | chr2:34275211-34275212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567965493 | chr2:34275225-34275226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142234292 | chr2:34275259-34275260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4670314 | chr2:34275263-34275264 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs184122822 | chr2:34275292-34275293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542259251 | chr2:34275316-34275317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539284913 | chr2:34275379-34275380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552765160 | chr2:34275401-34275402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4671034 | chr2:34275402-34275403 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs10495808 | chr2:34275434-34275435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575612399 | chr2:34275517-34275518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574779511 | chr2:34275522-34275523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543833454 | chr2:34275539-34275540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368421666 | chr2:34275542-34275543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79112412 | chr2:34275550-34275551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546482754 | chr2:34275564-34275565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559715692 | chr2:34275609-34275610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187185758 | chr2:34275650-34275651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551668708 | chr2:34275653-34275654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560210686 | chr2:34275654-34275655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527239031 | chr2:34275659-34275660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77102403 | chr2:34275666-34275667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561820559 | chr2:34275684-34275685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191652124 | chr2:34275693-34275694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4670315 | chr2:34275757-34275758 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
49 | rs75762229 | chr2:34275772-34275773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539370765 | chr2:34275794-34275795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34270400-34270600 | Enhancers | Brain Substantia Nigra | brain |
2 | chr2:34275000-34276000 | Enhancers | Fetal Heart | heart |
3 | chr2:34284600-34285200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |